(Q24202923)

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Corticosteroids and ibuprofen in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

"CF asthma": what is it and what do we do about it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Anti-inflammatory approaches to cystic fibrosis airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Effectiveness of prophylactic inhaled steroids in childhood asthma: a systemic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Oral steroids for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Meta-analyses involving cross-over trials: methodological issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

International practice patterns by age and severity of lung disease in cystic fibrosis: data from the Epidemiologic Registry of Cystic Fibrosis (ERCF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Lung inflammation as a therapeutic target in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Bronchial hyperreactivity in cystic fibrosis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Symptomatic adrenal insufficiency during inhaled corticosteroid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Glucocorticoids for acute viral bronchiolitis in infants and young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

The use of inhaled corticosteroids during childhood: plus ça change...

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Iatrogenic adrenal insufficiency as a side-effect of combined treatment of itraconazole and budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

A population based case-control study of cataract and inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Adrenal suppression secondary to inhaled fluticasone propionate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Atopy and bronchial reactivity in older patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Beclomethasone diproprionate reduced airway inflammation without adrenal suppression in young children with cystic fibrosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Beclomethasone, budesonide and fluticasone propionate inhibit human neutrophil apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Inhaled corticosteroids for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Controlled Trial of Inhaled Budesonide in Patients with Cystic Fibrosis and Chronic BronchopulmonaryPseudomonas aeruginosaInfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

Multicenter Randomized Controlled Trial of Withdrawal of Inhaled Corticosteroids in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

7 January 2021

Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

7 January 2021

Patterns of medical practice in cystic fibrosis: part II. Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

7 January 2021

Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

7 January 2021

The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

7 January 2021

Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

7 January 2021

Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

7 January 2021

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

7 January 2021

Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

7 January 2021

Effects of short-term inhaled fluticasone on oxidative burst of sputum cells in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

7 January 2021

Effects of long-term treatment with corticosteroids in COPD

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001915.PUB3

7 January 2021